Dr Sabrina Bajwah
Consultant and Honorary Senior Lecturer
Dr Sabrina Bajwah is a Consultant and Honorary Senior Lecturer in the Department of Palliative Care, Policy & Rehabilitation (King’s College London). Having completed a MSc in Palliative Care and a MA in the Ethics of Cancer and Palliative Care, she has recently completed her PhD in complex interventions for patients with end stage interstitial lung disease. During her PhD she developed a complex intervention at the end of life for patients with end stage interstitial lung disease. This intervention developed using the Medical Research Council Guidance, consisted of developing a case conference integrated model of care to improve symptom control and advance care planning across all settings. The intervention was trialled in a randomised control. Dr Bajwah has been a member of the NICE Quality Standards committee for Idiopathic Pulmonary Fibrosis and has also been a member of the Emergency Oxygen Guideline Group for the British Thoracic Society and Idiopathic Pulmonary Fibrosis clinical and research advisory committees for the British Lung Foundation. She now works clinically within the palliative care team at King’s College NHS Foundation Trust and runs a palliative care respiratory clinic whilst continuing to work on respiratory palliative care research.
- Higginson IJ, Reilly CC, Bajwah S, Maddocks M, Constantini M, Wei G. Which patients with advanced disease die in hospital: a 14 year population-based study of trends and associated factors? BMC Medicine 2017 DOI 10.1186/s12916-016-0776
- Boland, J., Reigada, C., Yorke, J., Wells, A., Ross, J., Bajwah, S., Papadopoulos, A., Currow, D., Grande, G., Hart, S., Macleod, U., & Johnson, M. (2015). The adaptation, face and content validation of a Palliative Care Needs Assessment Tool for people with Interstitial Lung Diseases. Journal of Palliative Medicine February 2016 doi:10.1089/jpm.2015.0355.
- Bajwah S, Ross JR, Wells AU, Mohammed K, Oyebode C, Birring SS, Koffman J, Higginson IJ, Riley J. Palliative Care for Patients with Advanced Fibrotic Lung Disease: a randomised controlled phase II and feasibility trial of a case conference intervention. Thorax 2015;70(9):830-9
- Patel A, Siegert R, Bajwah S, Brignall K, Gosker HR, Moxham J, Maher T, Renzoni E, Wells AU, Higginson Irene, Birring S. A comparison of Rasch Analysis and Impact factor methodology for constructing an interstitial lung disease health status questionnaire.J Clin Epidemiol 2015;68(9):1019-27.
- Patel A, Siegert R, Bajwah S, Brignall K, Gosker HR, Moxham J, Maher T, Renzoni E, Wells AU, Higginson Irene, Birring S. The minimal important difference of health status and forced vital capacity in interstitial lung disease. Respiratory Medicine 2013 Sep;107(9):1438-1443
- Bajwah S, Higginson IJ, Ross JR, Wells AU, Birring SS, Riley J, Koffman J. The palliative care needs for fibrotic interstitial lung disease: A qualitative study of patients, informal caregivers and health professionals. Palliative Medicine 2013;27(9):869-876
- Bajwah S, Ross JR, Peacock JL, Higginson IJ, Wells AU, Patel A, Koffman J, Riley J. Interventions to improve symptoms and quality of life of patients with fibrotic ILD: a systematic review of the literature. December Thorax 2013 Sep;68(9):867-79
- Bajwah S, Koffman J, Higginson IJ, Ross JR, Wells AU, Birring SS, Riley J. “I wish I knew more….” - the end-of-life planning and information needs for end-stage fibrotic interstitial lung disease: views of patients, carers and health professionals. BMJ Supportive & Palliative Care 2013;3:84-90
- Bajwah S, Laird DL. Recognising the palliative care needs of idiopathic pulmonary fibrosis European Journal of Palliative Care 2012;19(5): 222-223
- Bajwah S, Higginson IJ, Ross JR, Wells AU, Birring SS, Patel A, Riley J. Specialist palliative care is more than drugs: a retrospective study of ILD patients. Lung 2012;190(2):215-20
“Learning and sharing innovation in breathlessness management (E-Breathe)” £48,000 Co-applicant- The Health Foundation, Evidence into Practice 2016
“An evidence synthesis of holistic services for refractory breathlessness in advanced malignant and non-malignant disease” £120,000 Co-applicant- NIHR HS&DR 2016
“Systematic review and meta-analysis of the effectiveness and cost-effectiveness of inpatient specialist palliative care in acute hospitals for adults with advanced illness and their caregivers” £120,000 Chief Investigator- NIHR HS&DR 2016
“Pharmacological and non-pharmacological interventions to improve symptom control and quality of life in patients with interstitial lung disease: a systematic review” £65,000 Chief Investigator- NIHR RfPB
“The adaptation and validation of an assessment tool to identify the palliative care needs of people with irreversible idiopathic interstitial lung disease for use in every day clinical practice.” £ 119,000 Co-applicant- Marie Curie